Biogen Shares Rise on Q4 Earnings Beat Despite Lower Revenue Outlook
Shares of Biogen Inc (BIIB) rose 8.53% to $201.18 at close on Friday following the release of fourth-quarter and full-year...
Shares of Biogen Inc (BIIB) rose 8.53% to $201.18 at close on Friday following the release of fourth-quarter and full-year...
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported lower revenues and adjusted earnings for the fourth quarter of fiscal 2025. The...
Roivant Sciences (Nasdaq: ROIV) reported its financial results for the fiscal third quarter ended December 31, 2025, underscored by positive...
Roivant Sciences (Nasdaq: ROIV) on Friday reported its financial results for the fiscal third quarter ended December 31, 2025, revealing...